Global Nuclear Drug for Therapeutic Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nuclear Drug for Therapeutic Market Size 2017-2028

2.1.2 Nuclear Drug for Therapeutic Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Nuclear Drug for Therapeutic Segment by Type

2.2.1 Radium-223

2.2.2 Lutetium-177

2.2.3 Iodine-131

2.2.4 Other

2.3 Nuclear Drug for Therapeutic Market Size by Type

2.3.1 Nuclear Drug for Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Nuclear Drug for Therapeutic Market Size Market Share by Type (2017-2022)

2.4 Nuclear Drug for Therapeutic Segment by Application

2.4.1 Thyroid

2.4.2 Bone Metastasis

2.4.3 Lymphoma

2.4.4 Other

2.5 Nuclear Drug for Therapeutic Market Size by Application

2.5.1 Nuclear Drug for Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Nuclear Drug for Therapeutic Market Size Market Share by Application (2017-2022)

3 Nuclear Drug for Therapeutic Market Size by Player

3.1 Nuclear Drug for Therapeutic Market Size Market Share by Players

3.1.1 Global Nuclear Drug for Therapeutic Revenue by Players (2020-2022)

3.1.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Players (2020-2022)

3.2 Global Nuclear Drug for Therapeutic Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Nuclear Drug for Therapeutic by Regions

4.1 Nuclear Drug for Therapeutic Market Size by Regions (2017-2022)

4.2 Americas Nuclear Drug for Therapeutic Market Size Growth (2017-2022)

4.3 APAC Nuclear Drug for Therapeutic Market Size Growth (2017-2022)

4.4 Europe Nuclear Drug for Therapeutic Market Size Growth (2017-2022)

4.5 Middle East & Africa Nuclear Drug for Therapeutic Market Size Growth (2017-2022)

5 Americas

5.1 Americas Nuclear Drug for Therapeutic Market Size by Country (2017-2022)

5.2 Americas Nuclear Drug for Therapeutic Market Size by Type (2017-2022)

5.3 Americas Nuclear Drug for Therapeutic Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Nuclear Drug for Therapeutic Market Size by Region (2017-2022)

6.2 APAC Nuclear Drug for Therapeutic Market Size by Type (2017-2022)

6.3 APAC Nuclear Drug for Therapeutic Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Nuclear Drug for Therapeutic by Country (2017-2022)

7.2 Europe Nuclear Drug for Therapeutic Market Size by Type (2017-2022)

7.3 Europe Nuclear Drug for Therapeutic Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Nuclear Drug for Therapeutic by Region (2017-2022)

8.2 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2017-2022)

8.3 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Nuclear Drug for Therapeutic Market Forecast

10.1 Global Nuclear Drug for Therapeutic Forecast by Regions (2023-2028)

10.1.1 Global Nuclear Drug for Therapeutic Forecast by Regions (2023-2028)

10.1.2 Americas Nuclear Drug for Therapeutic Forecast

10.1.3 APAC Nuclear Drug for Therapeutic Forecast

10.1.4 Europe Nuclear Drug for Therapeutic Forecast

10.1.5 Middle East & Africa Nuclear Drug for Therapeutic Forecast

10.2 Americas Nuclear Drug for Therapeutic Forecast by Country (2023-2028)

10.2.1 United States Nuclear Drug for Therapeutic Market Forecast

10.2.2 Canada Nuclear Drug for Therapeutic Market Forecast

10.2.3 Mexico Nuclear Drug for Therapeutic Market Forecast

10.2.4 Brazil Nuclear Drug for Therapeutic Market Forecast

10.3 APAC Nuclear Drug for Therapeutic Forecast by Region (2023-2028)

10.3.1 China Nuclear Drug for Therapeutic Market Forecast

10.3.2 Japan Nuclear Drug for Therapeutic Market Forecast

10.3.3 Korea Nuclear Drug for Therapeutic Market Forecast

10.3.4 Southeast Asia Nuclear Drug for Therapeutic Market Forecast

10.3.5 India Nuclear Drug for Therapeutic Market Forecast

10.3.6 Australia Nuclear Drug for Therapeutic Market Forecast

10.4 Europe Nuclear Drug for Therapeutic Forecast by Country (2023-2028)

10.4.1 Germany Nuclear Drug for Therapeutic Market Forecast

10.4.2 France Nuclear Drug for Therapeutic Market Forecast

10.4.3 UK Nuclear Drug for Therapeutic Market Forecast

10.4.4 Italy Nuclear Drug for Therapeutic Market Forecast

10.4.5 Russia Nuclear Drug for Therapeutic Market Forecast

10.5 Middle East & Africa Nuclear Drug for Therapeutic Forecast by Region (2023-2028)

10.5.1 Egypt Nuclear Drug for Therapeutic Market Forecast

10.5.2 South Africa Nuclear Drug for Therapeutic Market Forecast

10.5.3 Israel Nuclear Drug for Therapeutic Market Forecast

10.5.4 Turkey Nuclear Drug for Therapeutic Market Forecast

10.5.5 GCC Countries Nuclear Drug for Therapeutic Market Forecast

10.6 Global Nuclear Drug for Therapeutic Forecast by Type (2023-2028)

10.7 Global Nuclear Drug for Therapeutic Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Bayer

11.1.1 Bayer Company Information

11.1.2 Bayer Nuclear Drug for Therapeutic Product Offered

11.1.3 Bayer Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Bayer Main Business Overview

11.1.5 Bayer Latest Developments

11.2 Novartis

11.2.1 Novartis Company Information

11.2.2 Novartis Nuclear Drug for Therapeutic Product Offered

11.2.3 Novartis Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Novartis Main Business Overview

11.2.5 Novartis Latest Developments

11.3 China Isotope & Radiation

11.3.1 China Isotope & Radiation Company Information

11.3.2 China Isotope & Radiation Nuclear Drug for Therapeutic Product Offered

11.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 China Isotope & Radiation Main Business Overview

11.3.5 China Isotope & Radiation Latest Developments

11.4 Dongcheng

11.4.1 Dongcheng Company Information

11.4.2 Dongcheng Nuclear Drug for Therapeutic Product Offered

11.4.3 Dongcheng Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Dongcheng Main Business Overview

11.4.5 Dongcheng Latest Developments

11.5 Q BioMed

11.5.1 Q BioMed Company Information

11.5.2 Q BioMed Nuclear Drug for Therapeutic Product Offered

11.5.3 Q BioMed Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Q BioMed Main Business Overview

11.5.5 Q BioMed Latest Developments

11.6 Curium Pharmaceuticals

11.6.1 Curium Pharmaceuticals Company Information

11.6.2 Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Offered

11.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Curium Pharmaceuticals Main Business Overview

11.6.5 Curium Pharmaceuticals Latest Developments

11.7 Jubilant DraxImage

11.7.1 Jubilant DraxImage Company Information

11.7.2 Jubilant DraxImage Nuclear Drug for Therapeutic Product Offered

11.7.3 Jubilant DraxImage Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Jubilant DraxImage Main Business Overview

11.7.5 Jubilant DraxImage Latest Developments

11.8 Lantheus

11.8.1 Lantheus Company Information

11.8.2 Lantheus Nuclear Drug for Therapeutic Product Offered

11.8.3 Lantheus Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Lantheus Main Business Overview

11.8.5 Lantheus Latest Developments

11.9 Spectrum Pharmaceuticals

11.9.1 Spectrum Pharmaceuticals Company Information

11.9.2 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Product Offered

11.9.3 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Spectrum Pharmaceuticals Main Business Overview

11.9.5 Spectrum Pharmaceuticals Latest Developments

11.10 Progenics Pharmaceuticals

11.10.1 Progenics Pharmaceuticals Company Information

11.10.2 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Product Offered

11.10.3 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Progenics Pharmaceuticals Main Business Overview

11.10.5 Progenics Pharmaceuticals Latest Developments

11.11 International Isotopes

11.11.1 International Isotopes Company Information

11.11.2 International Isotopes Nuclear Drug for Therapeutic Product Offered

11.11.3 International Isotopes Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 International Isotopes Main Business Overview

11.11.5 International Isotopes Latest Developments

12 Research Findings and Conclusion

Table 1. Nuclear Drug for Therapeutic Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Radium-223

Table 3. Major Players of Lutetium-177

Table 4. Major Players of Iodine-131

Table 5. Major Players of Other

Table 6. Nuclear Drug for Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Nuclear Drug for Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Nuclear Drug for Therapeutic Market Size Market Share by Type (2017-2022)

Table 9. Nuclear Drug for Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Nuclear Drug for Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Nuclear Drug for Therapeutic Market Size Market Share by Application (2017-2022)

Table 12. Global Nuclear Drug for Therapeutic Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Nuclear Drug for Therapeutic Revenue Market Share by Player (2020-2022)

Table 14. Nuclear Drug for Therapeutic Key Players Head office and Products Offered

Table 15. Nuclear Drug for Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Nuclear Drug for Therapeutic Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Nuclear Drug for Therapeutic Market Size Market Share by Regions (2017-2022)

Table 20. Americas Nuclear Drug for Therapeutic Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Nuclear Drug for Therapeutic Market Size Market Share by Country (2017-2022)

Table 22. Americas Nuclear Drug for Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Nuclear Drug for Therapeutic Market Size Market Share by Type (2017-2022)

Table 24. Americas Nuclear Drug for Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Nuclear Drug for Therapeutic Market Size Market Share by Application (2017-2022)

Table 26. APAC Nuclear Drug for Therapeutic Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Nuclear Drug for Therapeutic Market Size Market Share by Region (2017-2022)

Table 28. APAC Nuclear Drug for Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Nuclear Drug for Therapeutic Market Size Market Share by Type (2017-2022)

Table 30. APAC Nuclear Drug for Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Nuclear Drug for Therapeutic Market Size Market Share by Application (2017-2022)

Table 32. Europe Nuclear Drug for Therapeutic Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Nuclear Drug for Therapeutic Market Size Market Share by Country (2017-2022)

Table 34. Europe Nuclear Drug for Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Nuclear Drug for Therapeutic Market Size Market Share by Type (2017-2022)

Table 36. Europe Nuclear Drug for Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Nuclear Drug for Therapeutic Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Nuclear Drug for Therapeutic

Table 45. Key Market Challenges & Risks of Nuclear Drug for Therapeutic

Table 46. Key Industry Trends of Nuclear Drug for Therapeutic

Table 47. Global Nuclear Drug for Therapeutic Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Nuclear Drug for Therapeutic Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Nuclear Drug for Therapeutic Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Nuclear Drug for Therapeutic Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Nuclear Drug for Therapeutic Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Nuclear Drug for Therapeutic Market Size Market Share Forecast by Application (2023-2028)

Table 53. Bayer Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors

Table 54. Bayer Nuclear Drug for Therapeutic Product Offered

Table 55. Bayer Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Bayer Main Business

Table 57. Bayer Latest Developments

Table 58. Novartis Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors

Table 59. Novartis Nuclear Drug for Therapeutic Product Offered

Table 60. Novartis Main Business

Table 61. Novartis Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Novartis Latest Developments

Table 63. China Isotope & Radiation Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors

Table 64. China Isotope & Radiation Nuclear Drug for Therapeutic Product Offered

Table 65. China Isotope & Radiation Main Business

Table 66. China Isotope & Radiation Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. China Isotope & Radiation Latest Developments

Table 68. Dongcheng Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors

Table 69. Dongcheng Nuclear Drug for Therapeutic Product Offered

Table 70. Dongcheng Main Business

Table 71. Dongcheng Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Dongcheng Latest Developments

Table 73. Q BioMed Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors

Table 74. Q BioMed Nuclear Drug for Therapeutic Product Offered

Table 75. Q BioMed Main Business

Table 76. Q BioMed Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Q BioMed Latest Developments

Table 78. Curium Pharmaceuticals Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors

Table 79. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Offered

Table 80. Curium Pharmaceuticals Main Business

Table 81. Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Curium Pharmaceuticals Latest Developments

Table 83. Jubilant DraxImage Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors

Table 84. Jubilant DraxImage Nuclear Drug for Therapeutic Product Offered

Table 85. Jubilant DraxImage Main Business

Table 86. Jubilant DraxImage Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Jubilant DraxImage Latest Developments

Table 88. Lantheus Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors

Table 89. Lantheus Nuclear Drug for Therapeutic Product Offered

Table 90. Lantheus Main Business

Table 91. Lantheus Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Lantheus Latest Developments

Table 93. Spectrum Pharmaceuticals Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors

Table 94. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Product Offered

Table 95. Spectrum Pharmaceuticals Main Business

Table 96. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Spectrum Pharmaceuticals Latest Developments

Table 98. Progenics Pharmaceuticals Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors

Table 99. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Product Offered

Table 100. Progenics Pharmaceuticals Main Business

Table 101. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Progenics Pharmaceuticals Latest Developments

Table 103. International Isotopes Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors

Table 104. International Isotopes Nuclear Drug for Therapeutic Product Offered

Table 105. International Isotopes Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. International Isotopes Main Business

Table 107. International Isotopes Latest Developments

List of Figures

Figure 1. Nuclear Drug for Therapeutic Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Nuclear Drug for Therapeutic Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Nuclear Drug for Therapeutic Market Size Market Share by Type in 2021

Figure 7. Nuclear Drug for Therapeutic in Thyroid

Figure 8. Global Nuclear Drug for Therapeutic Market: Thyroid (2017-2022) & ($ Millions)

Figure 9. Nuclear Drug for Therapeutic in Bone Metastasis

Figure 10. Global Nuclear Drug for Therapeutic Market: Bone Metastasis (2017-2022) & ($ Millions)

Figure 11. Nuclear Drug for Therapeutic in Lymphoma

Figure 12. Global Nuclear Drug for Therapeutic Market: Lymphoma (2017-2022) & ($ Millions)

Figure 13. Nuclear Drug for Therapeutic in Other

Figure 14. Global Nuclear Drug for Therapeutic Market: Other (2017-2022) & ($ Millions)

Figure 15. Global Nuclear Drug for Therapeutic Market Size Market Share by Application in 2021

Figure 16. Global Nuclear Drug for Therapeutic Revenue Market Share by Player in 2021

Figure 17. Global Nuclear Drug for Therapeutic Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Nuclear Drug for Therapeutic Market Size 2017-2022 ($ Millions)

Figure 19. APAC Nuclear Drug for Therapeutic Market Size 2017-2022 ($ Millions)

Figure 20. Europe Nuclear Drug for Therapeutic Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Nuclear Drug for Therapeutic Market Size 2017-2022 ($ Millions)

Figure 22. Americas Nuclear Drug for Therapeutic Value Market Share by Country in 2021

Figure 23. Americas Nuclear Drug for Therapeutic Consumption Market Share by Type in 2021

Figure 24. Americas Nuclear Drug for Therapeutic Market Size Market Share by Application in 2021

Figure 25. United States Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Nuclear Drug for Therapeutic Market Size Market Share by Region in 2021

Figure 30. APAC Nuclear Drug for Therapeutic Market Size Market Share by Application in 2021

Figure 31. China Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Nuclear Drug for Therapeutic Market Size Market Share by Country in 2021

Figure 38. Europe Nuclear Drug for Therapeutic Market Size Market Share by Type in 2021

Figure 39. Europe Nuclear Drug for Therapeutic Market Size Market Share by Application in 2021

Figure 40. Germany Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Application in 2021

Figure 48. Egypt Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Nuclear Drug for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 54. APAC Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 55. Europe Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 57. United States Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 58. Canada Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 61. China Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 62. Japan Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 63. Korea Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 65. India Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 66. Australia Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 67. Germany Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 68. France Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 69. UK Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 70. Italy Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 71. Russia Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 72. Spain Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 75. Israel Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Nuclear Drug for Therapeutic Market Size 2023-2028 ($ Millions)